Behind the Scenes: Brigham Teams Drive COVID-19 Vaccine Trials
Infectious diseases experts, pharmacists, clinicians and outreach workers joined together to support clinical trials of COVID-19 vaccine candidates
Fueling COVID Innovation
Funding from local and national sources as well as an outpouring of support from donors is helping make possible scientific projects tackling the COVID-19 pandemic from many angles
Center for COVID Innovation Accelerates Diagnostics
Mass General and Brigham researchers have scoured the world for the most promising diagnostics and are now poised to put the top candidates through the paces. Their results may help usher in the next phase of the pandemic response
Brigham Team Develops a Safer Way to Use A Single Ventilator for Multiple Patients
A team led by Brigham and MIT experts in bioengineering and pulmonology has developed the Individualized System for Augmenting Ventilator Efficacy (iSAVE), which can be built from off-the shelf components and allows for patient-specific volume and pressure control
Next Generation: I Was a Doctor With COVID-19 — And I Will Not Be the Last
Maxwell Coll, MD, an internal medicine resident, shares his experience of being diagnosed with and recovering from COVID-19
Enlisting the Tools of Genomics in the Fight Against COVID-19
The Sherwood lab is using CRISPR gene editing and other techniques to better understand the risks associated with experimental treatments for COVID-19 and whether there are any readily available ways to decrease these risks
Q&A with Paul Anderson, MD, PhD: Research and Innovation in the Time of COVID-19
Paul Anderson, MD, PhD, senior vice president of research and education, reflects on the extraordinary collaboration and commitment of the Brigham research community during the COVID-19 crisis
Building on Dermatology’s Legacy to Develop a Universal Coronavirus Vaccine
Brigham investigators are leveraging their efforts on a universal flu vaccine to rapidly develop a vaccine to protect against COVID-19 and future strains of coronavirus
Two Remdesivir Clinical Trials Underway at the Brigham
The Brigham is a clinical trial site for evaluating an antiviral medication for patients with COVID-19; a research team is working behind the scenes to help patients get enrolled
Written in Blood: Looking for Signals in Samples from the Recovered
Investigators from the Brigham are working on a critical piece of the COVID-19 puzzle: understanding recovery
Developing New Protective Materials in the Fight Against COVID-19
The Karp lab is innovating under constraint to develop a long-lasting sanitizer and an anti-viral nasal spray to help their clinical colleagues on the COVID-19 front lines
Accelerating COVID-19 Testing for Admitted Patients
Collaborative team is working to provide in-house COVID-19 testing at the Brigham for admitted patients
Innovations Around COVID-19: Using Sewage to Map an Outbreak
Peter Chai, MD, and collaborators want to use sewage sampling to illuminate how COVID-19 is spreading in communities to help understand and address its rise
Staying Connected
The Dhand lab, which studies the connections between individuals and their social networks, is learning firsthand how to stay connected amidst social distancing precautions